Friday, Sept. 6, at noon ET
The Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), and state partners will give updates on the investigation into cases of pulmonary disease among people who use e-cigarettes, and discuss initial findings published Friday.
-
Ileana Arias, PhD, acting deputy director, Non-Infectious Diseases, CDC
-
Dana Meaney-Delman, MD, MPH, incident manager, CDC 2019 Lung Injury Response
-
Daniel Fox, MD, Pulmonary & Critical Care Medicine, WakeMed Health & Hospitals (NC)
-
Jonathan Meiman, MD, chief medical officer, Wisconsin Department of Health Services
-
Jennifer Layden, MD, PhD, chief medical officer and state epidemiologist, Illinois Department of Public Health
-
Mitch Zeller, JD, director, Center for Tobacco Products, FDA
-
Brian King, PhD, MPH, deputy director, Research Translation, Office on Smoking and Health, CDC
Dial-In
Media: 888-795-0855
Non-Media: 888-972-6892
INTERNATIONAL: 1-517-308-9298
PASSCODE: CDC Media
Important Instructions
If you would like to ask a question during the call, press *1 on your touchtone phone. Press *2 to withdraw your question. You may queue up at any time. You will hear a tone to indicate your question is pending.
A transcript and audio will be available following the briefing at CDC’s web site.
Contact: CDC Media Relations, (404) 639-3286